Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Mol Pharm. 2017 Mar 30;14(5):1450–1459. doi: 10.1021/acs.molpharmaceut.6b01178

Table 1.

Characterization of the Cathepsin B Cleavable Diblock Copolymers (PolCathBIM and PolCathScrBIM) and Peptide-PEGMA copolymers (Pol950 and Pol300)a

pH-responsive block
hydrophilic block
% feed/comp
% feed/comp
polymer DP DEAEMA BMA Mn PDI DP PEGMA peptide Mn Đ
PolCathBIM 200 60/55 40/45 16,600 1.07 45 96/97 4/3 28,700 1.12
PolCathScrBIM 200 60/55 40/45 16,600 1.07 45 96/98 4/2 29,200 1.07
Pol950 25 96/95 4/5 19,000 1.07
Pol300 50 96/96 4/4 18,800 1.08
a

For the synthesis of diblock copolymers, a poly[(DEAEMA)-co-(BMA)] macroCTA was synthesized and employed for block copolymerization of PEGMA300 and MaCathBIM (PolCathBIM) or MaCathScrBIM (PolCathScrBIM). To investigate the effect of PEGMA chain length on cathepsin B cleavage, MaCathBIM peptide monomer was copolymerized with either PEGMA950 (Pol950) or PEGMA300 (Pol300). Polymer molecular weights (Mns) and molar mass dispersities (Đ) were determined by GPC. Molar compositions were determined by 1H NMR and RP-HPLC analysis of reaction aliquots taken at t0 and tx.